Smart Devices Are Poised to Revolutionize the Usefulness of Respiratory Sounds

A Yale study finds that Tocilizumab, when given to the most severely ill COVID-19 patients— specifically, those experiencing a dangerous immune response known as a “cytokine storm”—it appeared to improve survival rates up to​ 87%, especially among patients requiring mechanical ventilation.